SCHEMBL29346256

SCHEMBL29346256

C[C@@](N)(Cc1ccc(B(O)O)cc1OCc1ccccc1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPE Q05469 1/20 0.44
BLM P54132 2/20 0.41
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
EGFR P00533 1/20 0.39
CYP1A2 P05177 1/20 0.39
FYN P06241 1/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.39
APEX1 P27695 1/20 0.39
ADRA1A P35348 1/20 0.39
PTGS2 P35354 1/20 0.39
MTOR P42345 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27207984 1.00 LIPE (0.44) LIPEBLMHPGDKDM4EMEN1
SCHEMBL27230222 1.00 LIPE (0.44) LIPEBLMHPGDKDM4EMEN1
SCHEMBL29346228 0.83 BLM (0.40) BLMHPGDKDM4EMEN1USP2
SCHEMBL29346229 0.83 BLM (0.40) BLMHPGDKDM4EMEN1USP2
SCHEMBL24802253 0.76 PTGER1 (0.56) LIPEKDM4EPOLBMAPTRECQL
SCHEMBL29346226 0.76 CYP1A2 (0.43) BLMHPGDKDM4EMEN1USP2
SCHEMBL29346227 0.76 CYP1A2 (0.43) BLMHPGDKDM4EMEN1USP2
SCHEMBL29346254 0.76 ALDH1A1 (0.43) BLMHPGDKDM4EMEN1USP2
SCHEMBL29346222 0.75 ALDH1A1 (0.42) BLMHPGDKDM4EMEN1USP2
SCHEMBL29346230 0.75 BLM (0.42) BLMHPGDKDM4EMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239816-A1 BORONO-PHENYLALANINE DERIVATIVE STELLA PHARMA CORPORATION (JP) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239816-A1 BORONO-PHENYLALANINE DERIVATIVE SLC7A1, SLC1A5, LATS2 LIPE 3937/4885BLM 3131/4885HPGD 3897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.